Plasmablastic lymphoma
Cancers in People with HIV and AIDS: Progress and Challenges, Page: 223-234
2014
- 3Citations
- 8Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Plasmablastic lymphoma (PBL) is a rare, aggressive lymphoma that is mainly seen in the human immunodeficiency virus (HIV)-positive population. It is a mature large B-cell lymphoma exhibiting plasmablastic morphology and with terminal B-cell, namely plasma cell-like, differentiation. PBL has a tendency to occur in the oral cavity; however, extraoral involvement is not infrequently encountered. While PBL shares some overlapping morphologic and immunophenotypic features with other mature B-cell lymphomas, PBL is currently classified as a distinct entity in the 2008 World Health Organization (WHO) Classification Tumors of Haematopoietic and Lymphoid Tissues (Swerdlow et al., WHO classification of tumours of haematopoietic and lymphoid tissues; 2008).
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84930244952&origin=inward; http://dx.doi.org/10.1007/978-1-4939-0859-2_16; https://link.springer.com/10.1007/978-1-4939-0859-2_16; https://dx.doi.org/10.1007/978-1-4939-0859-2_16; https://link.springer.com/chapter/10.1007/978-1-4939-0859-2_16
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know